Viktor Tasselius
-
A type I interferon footprint in pre-operative biopsies is an independent biomarker that in combination with CD8(+) T cell quantification can improve the prediction of response to neoadjuvant treatment of rectal
adenocarcinoma
Azar Rezapour, Daniel Rydbeck, Fabian Byvald, Viktor Tasselius, G. Danielsson, Eva Angenete, Ulf Yrlid
OncoImmunology - 2023